Glaucoma management varies widely in the UK

Article

The methods used to manage glaucoma vary widely across the United Kingdom, according to study results published in the November issue of Eye.

The methods used to manage glaucoma vary widely across the United Kingdom, according to study results published in the November issue of Eye.

Patel S. C. Gordon-Bennett of Broomfield Hospital, Essex, UK and colleagues conducted a questionnaire of National Health Service (NHS) consultant ophthalmologists; 493 questionnaires were completed and 469 were analysed.

Of the respondents, 60.6% were based in a general hospital and 39.4% were university-based; 30.7% were glaucoma specialists. Automated perimetry was available to 99.6% of respondents; disc photography, to 89.6%; pachymetry, 79.7%; OCT, 45.2%; HRT, 43.9% and GDx, 12.6%. A minimum of one digital imaging instrument was available for 65.7% of respondents. In glaucoma suspects, respondents used SAP (74.0%), SITA-fast (60.1%), Esterman (33.0%) and Goldmann fields (19.2%). Short-wave automated perimetry and frequency-doubled perimetry were in use but were not common. To monitor glaucoma, respondents used SAP (60.3%) and SITA-fast (42.0%).

The researchers concluded that the wide variety of instruments available is the reason for the high degree of variability in glaucoma management methods across the UK.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.